The manufacturer became aware of a pmcf final study report that was conducted by university of (b)(6) in the usa.The title of this report is ¿a retrospective data collection of the treatment of femoral fractures with the femoral nail greater trochanter (gt) of the t2 alpha femur antegrade gt/pf nailing system¿, which is associated with the stryker ¿t2 alpha femur antegrade gt/pf nailing¿ system.This report includes analysis of the clinical data that was collected on 9 patients, the cases in this study range from march 2019 through july 2020.During the review of the literature, it was not possible to establish a specific device details, patient information, and at this time no additional device information is available.It was reported that one patient experienced delayed healing.The report states: ¿delayed healing: (b)(6) female, bmi (b)(6) with a history of osteoporotic sub trochanteric 32-a3 closed fracture in her left femur and an impending fracture in her right femur.Both femurs were treated with t2 alpha gt nails.Her left femur fracture resulted in delayed healing 432 days post-op and her right impending fracture resulted in healing 180 days post-op.Therefore, this is probably a non-device related adverse event.¿.
|
This complaint has been generated based on findings discovered during post market surveillance pmcf study review.The alleged delayed healing included in the study could not be confirmed, since the device was not returned for evaluation and no other additional information will be made available.More detailed information about the patient medical history, the event circumstances, radiographs and the involved device(s) must be available in order to determine the root cause.If any additional information becomes available, the investigation will be reopened and re-evaluated accordingly.Device disposition is unknown.
|